Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Apply
Fruquintinib & FOLFIRI
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step